1. Ambrisentan

   • James E. Frampton

   Adis Drug Profile 17 August 2012 Pages: 215 - 226

   

2. Fenofibrate

   • Gillian M. Keating

   Adis Drug Evaluation 17 August 2012 Pages: 227 - 247

   

3. Fimasartan

   R&D Insight Profile 17 August 2012 Pages: 249 - 252

   

4. Attenuation of Rate of Change in Carotid Intima-Media Thickness by Lipid-Modifying Drugs

   • Sanne A. E. Peters
   • Hester M. den Ruijter
   • Michiel L. Bots

   Current Opinion 17 August 2012 Pages: 253 - 263

   

5. Role of Emerging Antithrombotic Therapy in the Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation

   • Prakash C. Deedwania
   • Grace W. Huang

   Review Article 17 August 2012 Pages: 265 - 275

   

6. Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation

   • Mohamed A. El-Haddad
   • Sandip K. Zalawadiya
   • Sony Jacob

   Original Research Article 17 August 2012 Pages: 277 - 284

   

7. The Correct Administration of Antihypertensive Drugs According to the Principles of Clinical Pharmacology

   • Suresh Samson

   Correspondence 17 August 2012 Pages: 285 - 285

8. The Authors’ Reply

   • S. Taddei
   • R. M. Bruno
   • L. Ghiadoni

   Correspondence 17 August 2012 Pages: 285 - 285